These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
909 related items for PubMed ID: 33623503
1. Semi-quantitative analysis of 18F fluorodeoxyglucose uptake in the assessment of disease activity and therapeutic response in rheumatoid arthritis: An institutional experience. Ravikanth R, Singh JK. World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503 [Abstract] [Full Text] [Related]
2. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, Tsushima Y, Takagishi K. Rheumatology (Oxford); 2012 Aug; 51(8):1484-91. PubMed ID: 22513145 [Abstract] [Full Text] [Related]
3. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A. Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653 [Abstract] [Full Text] [Related]
4. Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis? Tachibana M, Yonemoto Y, Okamura K, Suto T, Sakane H, Kaneko T, Dam TT, Okura C, Tajika T, Tsushima Y, Chikuda H. Arthritis Res Ther; 2020 Jul 25; 22(1):178. PubMed ID: 32711580 [Abstract] [Full Text] [Related]
6. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies. Vijayant V, Sarma M, Aurangabadkar H, Bichile L, Basu S. World J Radiol; 2012 Dec 28; 4(12):462-8. PubMed ID: 23320137 [Abstract] [Full Text] [Related]
7. Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT. Okamura K, Yonemoto Y, Okura C, Higuchi T, Tsushima Y, Takagishi K. BMC Musculoskelet Disord; 2014 Nov 22; 15():393. PubMed ID: 25417119 [Abstract] [Full Text] [Related]
8. FDG PET Imaging of Extremities in Rheumatoid Arthritis. Dhawan R, Lokitz K, Lokitz S, Caldito G, Takalkar AM. J La State Med Soc; 2016 Nov 22; 168(5):156-161. PubMed ID: 27797345 [Abstract] [Full Text] [Related]
9. Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score. Suto T, Okamura K, Yonemoto Y, Okura C, Tsushima Y, Takagishi K. Medicine (Baltimore); 2016 Feb 22; 95(7):e2841. PubMed ID: 26886646 [Abstract] [Full Text] [Related]
10. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. Beckers C, Ribbens C, André B, Marcelis S, Kaye O, Mathy L, Kaiser MJ, Hustinx R, Foidart J, Malaise MG. J Nucl Med; 2004 Jun 22; 45(6):956-64. PubMed ID: 15181130 [Abstract] [Full Text] [Related]
11. Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission. Rinkin C, Fosse P, Malaise O, Chapelier N, Horrion J, Seidel L, Albert A, Hustinx R, Malaise MG. BMC Rheumatol; 2021 Aug 04; 5(1):31. PubMed ID: 34344479 [Abstract] [Full Text] [Related]
12. Clinical utility of F-18 sodium fluoride PET/CT for estimating disease activity in patients with rheumatoid arthritis. Park HJ, Chang SH, Lee JW, Lee SM. Quant Imaging Med Surg; 2021 Apr 04; 11(4):1156-1169. PubMed ID: 33816157 [Abstract] [Full Text] [Related]
13. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis. Watanabe T, Takase-Minegishi K, Ihata A, Kunishita Y, Kishimoto D, Kamiyama R, Hama M, Yoshimi R, Kirino Y, Asami Y, Suda A, Ohno S, Tateishi U, Ueda A, Takeno M, Ishigatsubo Y. Mod Rheumatol; 2016 Apr 04; 26(2):180-7. PubMed ID: 26140472 [Abstract] [Full Text] [Related]
14. 18F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab. Fosse P, Kaiser MJ, Namur G, de Seny D, Malaise MG, Hustinx R. Eur J Hybrid Imaging; 2018 Apr 04; 2(1):6. PubMed ID: 29782593 [Abstract] [Full Text] [Related]
15. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Beckers C, Jeukens X, Ribbens C, André B, Marcelis S, Leclercq P, Kaiser MJ, Foidart J, Hustinx R, Malaise MG. Eur J Nucl Med Mol Imaging; 2006 Mar 04; 33(3):275-80. PubMed ID: 16247604 [Abstract] [Full Text] [Related]
16. Development and Validation of an 18 F-Fluorodeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Tool for the Evaluation of Joint Counts and Disease Activity in Patients With Rheumatoid Arthritis. Lee SJ, Jeong JH, Lee CH, Ahn BC, Eun JS, Kim NR, Kang JW, Nam EJ, Kang YM. Arthritis Rheumatol; 2019 Aug 04; 71(8):1232-1240. PubMed ID: 30771237 [Abstract] [Full Text] [Related]
17. Axillary lymph-node metabolic activity assessment on 18F-FDG-PET/CT in rheumatoid arthritis patients treated with biologic therapies. Dam TT, Okamura K, Nakajima T, Yonemoto Y, Suto T, Arisaka Y, Tomonaga H, Tachibana M, Tajika T, Vu LD, Chikuda H, Tsushima Y. Scand J Rheumatol; 2020 Mar 04; 49(2):96-104. PubMed ID: 31578102 [Abstract] [Full Text] [Related]
18. 18F-FDG and 18F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis. Reddy N, Raynor WY, Werner TJ, Baker JF, Alavi A, Revheim ME. Diagnostics (Basel); 2023 Jun 23; 13(13):. PubMed ID: 37443544 [Abstract] [Full Text] [Related]
19. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method. Suto T, Yonemoto Y, Okamura K, Okura C, Kaneko T, Kobayashi T, Tachibana M, Tsushima Y, Takagishi K. Mod Rheumatol; 2017 Sep 23; 27(5):820-827. PubMed ID: 27919199 [Abstract] [Full Text] [Related]
20. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Goerres GW, Forster A, Uebelhart D, Seifert B, Treyer V, Michel B, von Schulthess GK, Kaim AH. Clin Nucl Med; 2006 Jul 23; 31(7):386-90. PubMed ID: 16785804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]